Company news

Pacific Biosciences of California, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

PacBio Announces the Retirement of David Botstein, Ph.D., from its Board of Directors

December 10, 2023

PacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders

November 1, 2023

PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partners to PacBio Compatible

October 31, 2023

PacBio Announces Kinnex RNA Kits, Further Scaling HiFi Sequencing in Full-Length RNA, Single-Cell RNA and 16S rRNA Applications

October 30, 2023

PacBio Announces Third Quarter 2023 Financial Results

October 29, 2023

PacBio Announces Appointment of David Meline to Board of Directors

October 15, 2023

PacBio to Report Third Quarter 2023 Financial Results on October 30, 2023

October 11, 2023

PacBio Announces Complete Computational Workflow for Human Whole Genome Sequencing Data Analysis

October 10, 2023

PacBio Announces PacBio Capital

September 11, 2023

PacBio Announces Collaboration with Leading Library Preparation Automation Partners

September 6, 2023

PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care

August 6, 2023

PacBio Reports Equity Incentive Awards to New Employees Under Nasdaq Listing Rule 5635(c)(4)

August 3, 2023

PacBio Enters into Agreement to Acquire Apton Biosystems to Accelerate the Development of a Next Generation, High Throughput, Short-read Sequencer

August 1, 2023

PacBio Begins Commercialization of the Onso Short-Read Sequencing System

August 1, 2023

PacBio Announces Second Quarter 2023 Financial Results

August 1, 2023

PacBio to Report Second Quarter 2023 Financial Results on August 2, 2023

July 18, 2023

PacBio's Revio System Empowers Bioscientia to Scale Long-Read Whole Genome Sequencing and Unravel the Mysteries of Rare Disease

June 27, 2023

PacBio Announces a Private Convertible Exchange Transaction of $441 Million Principal Amount of 1.375% Convertible Senior Notes due 2030

June 25, 2023

PacBio and Radboud University Medical Center Team Up for New Discoveries in Rare Disease Research

June 13, 2023

PacBio Announces the Appointment of Olga Troyanskaya from Princeton University to the Scientific Advisory Board

May 29, 2023

PacBio to Present at BofA Securities 2023 Health Care Conference

May 2, 2023

PacBio Announces Record Revenue in First Quarter 2023

May 1, 2023

PacBio to Report First Quarter 2023 Financial Results on May 2, 2023

April 17, 2023

PacBio Announces New Nanobind Extraction Kits to Enable High-Throughput Workflows with Revio and Sequel Systems

April 4, 2023

PacBio and Corteva Agriscience Enable Groundbreaking Plant and Microbial Long-Read Sequencing Workflow on Revio System

March 27, 2023

PacBio Announces a New Informatics Analysis Method for Highly Homologous Genes

March 13, 2023

PacBio To Begin Commercial Shipment of Revio Systems

March 6, 2023

PacBio to Present at Cowen's 43rd Annual Health Care Conference

February 26, 2023

PacBio Announces Fourth Quarter and Fiscal Year 2022 Financial Results

February 15, 2023

PacBio to Expand MAS-Seq Technology to 16S rRNA and Bulk RNA-Seq Solutions

February 6, 2023

PacBio to Report Fourth Quarter and Full Year 2022 Financial Results on February 16, 2023

February 1, 2023

Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock

January 23, 2023

Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock

January 23, 2023

PacBio Celebrates Nature Methods Naming Long-Read Sequencing "Method of the Year"

January 12, 2023

PacBio Announces Record Orders, Including Orders for 76 Revio Systems Received in the Fourth Quarter of 2022

January 8, 2023

PacBio and the University of Tokyo Announce Bioinformatics Applications Collaboration

January 8, 2023

PacBio to Present at 41st Annual J.P. Morgan Healthcare Conference

December 27, 2022

PacBio and Boston Children's Hospital Collaborate to Investigate Novel Variants Inaccessible by Short-Read Sequencing

December 5, 2022

PacBio Announces Third Quarter 2022 Financial Results

November 6, 2022

PacBio Announces that Euan Ashley, M.D., Ph.D., Joseph Puglisi, Ph.D., and Jay Shendure, Ph.D., Join Newly Created Scientific Advisory Board

November 1, 2022

PacBio to Report Third Quarter Earnings on November 7 and Host Inaugural Investor Day on November 15

October 24, 2022

PacBio Announces Revio, a Revolutionary New Long Read Sequencing System Designed to Provide 15 Times More HiFi Data and Human Genomes at Scale for Under $1,000

October 24, 2022

PacBio Announces Onso, the Highly Accurate Short-Read Sequencing Platform

October 24, 2022

PacBio Launches Single-Cell Transcriptome Solution Ushering in a New Era of RNA Discovery

October 19, 2022

PacBio and Twist Bioscience Deliver Initial Portfolio of Target Enrichment Panels for HiFi Sequencing

October 18, 2022

PacBio Collaborates with Leading Researchers to Establish Long-Read Variant Frequency Consortium

October 17, 2022

PacBio Unveils a New Method for Comprehensive, Genome-wide Tandem Repeat Analysis

September 26, 2022

PacBio to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

September 6, 2022

PacBio to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit

August 4, 2022

PacBio Announces Second Quarter 2022 Financial Results

August 2, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 23 calls. Every call is listed under its year.

Decks

The 5 newest of 6 decks. Every deck is listed under its year.